Cargando…
Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms
A preclinical model of glioblastoma (GB) bystander cell therapy using human adipose mesenchymal stromal cells (hAMSCs) is used to address the issues of cell availability, quality, and feasibility of tumor cure. We show that a fast proliferating variety of hAMSCs expressing thymidine kinase (TK) has...
Autores principales: | Guerra-Rebollo, Marta, Nogueira de Moraes, Carolina, Alcoholado, Cristina, Soler-Botija, Carolina, Sanchez-Cid, Lourdes, Vila, Olaia F., Meca-Cortés, Oscar, Ramos-Romero, Sara, Rubio, Nuria, Becerra, José, Blanco, Jeronimo, Garrido, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197388/ https://www.ncbi.nlm.nih.gov/pubmed/30364660 http://dx.doi.org/10.1016/j.omto.2018.09.002 |
Ejemplares similares
-
Targeting of replicating CD133 and OCT4/SOX2 expressing glioma stem cells selects a cell population that reinitiates tumors upon release of therapeutic pressure
por: Guerra-Rebollo, Marta, et al.
Publicado: (2019) -
CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice
por: Meca-Cortés, Oscar, et al.
Publicado: (2017) -
Glioblastoma Therapy with Cytotoxic Mesenchymal Stromal Cells Optimized by Bioluminescence Imaging of Tumor and Therapeutic Cell Response
por: Alieva, Maria, et al.
Publicado: (2012) -
Suicide gene therapy by canine mesenchymal stem cell transduced with thymidine kinase in a u-87 glioblastoma murine model: Secretory profile and antitumor activity
por: Villatoro, Antonio J., et al.
Publicado: (2022) -
Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas
por: Fornaguera, Cristina, et al.
Publicado: (2018)